WellTheory's official brand image - the care platform built by patients, for patients.
The autoimmune care company that figured out what 50 million patients already knew: the doctor's office isn't enough.
Somewhere in America right now, a woman with Hashimoto's Thyroiditis is sitting in a waiting room for her quarterly checkup. She has a list of symptoms she's been tracking for three months. Her appointment will last eleven minutes. She'll leave with a lab order, a prescription refill, and no real answers about why she's exhausted by 2pm every day.
WellTheory was built for her.
The San Francisco-based virtual care platform pairs licensed registered dietitians, board-certified health coaches, and advanced at-home diagnostics to give autoimmune patients something the traditional system rarely offers: time, attention, and a plan that goes beyond the prescription pad. The company supports over 100 autoimmune and inflammatory conditions - Hashimoto's, rheumatoid arthritis, celiac, psoriasis, and dozens more - through a 12-month structured membership that treats the whole person, not just the lab value.
"Finally being listened to, heard, and believed was one of the most critical parts of my own healing journey. I see you. I believe you. WellTheory was created for you."
- Ellen Rudolph, Co-Founder & CEOThe numbers are not soft. Independent actuarial analysis shows WellTheory members reduce emergency room and urgent care visits by 85% within 16 weeks. Average annual healthcare savings run $5,181 per patient - and for patients on biologics, that figure climbs to $9,390. Membership grew 10x year-over-year. Revenue grew 5x. This is what happens when a startup correctly reads a market that medicine misread for decades.
More than 50 million Americans live with autoimmune disease. Eighty percent of them are women. The average patient waits 4.5 years for a diagnosis and sees five or more specialists before one of them connects the dots. The conditions are real, the suffering is real, and the standard of care - a rheumatologist for joints, a gastroenterologist for gut, an endocrinologist for thyroid - fragments people into body parts.
Nobody looks at the food. Nobody asks about sleep. Nobody asks about stress. Nobody thinks to check whether the afternoon fatigue and the foggy mornings and the joint pain and the gut discomfort might all be the same fire burning in different rooms.
The $150 billion autoimmune care market is enormous. The gap in intelligent, whole-person care is larger.
Lifestyle medicine - the evidence-based practice of using diet, movement, sleep, and stress management as clinical tools - has a mountain of research behind it. It also has almost no representation in the 12-minute appointment model. WellTheory exists precisely at that gap.
Ellen Rudolph was 25 when she was diagnosed with an autoimmune condition. She had already built product at Everlane and Oscar Health, and knew what it looked like when a system failed its users. The autoimmune care system was failing its users at scale.
She co-founded WellTheory in 2020 with her sister Claire Rudolph, who leads product, and Wallace Torres, who runs operations. All three have personal autoimmune diagnoses. That's not a brand story - it's why the product works. The founders didn't build something they thought patients needed. They built the care they needed themselves.
Ellen's bet was specific: personalized, evidence-based nutrition and lifestyle interventions, delivered by practitioners who've lived with these conditions themselves, would outperform the reactive pharmaceutical model on both outcomes and cost. It was a high-conviction call. The data is proving it right.
"Now is the time to bring bio-individual, evidence-based nutrition and lifestyle recommendations to the forefront to usher autoimmune disease care into the 21st century."
- Ellen Rudolph, Co-Founder & CEOThe membership model is deliberate. Phase one spans six months of intensive 1-on-1 video sessions with a registered dietitian and health coach, held twice a month. Phase two is a six-month maintenance track with monthly check-ins. Both phases include unlimited messaging with the care team, advanced at-home laboratory testing, personalized care plans, and access to a community of members navigating similar conditions.
The diagnostics are not standard. WellTheory runs CLIA-certified, CAP-accredited remote lab testing covering vitamins, hormones, and autoimmune biomarkers - the kind of granular panel that traditional primary care rarely orders, let alone interprets in context of diet and lifestyle. An AI-powered Root Cause Assessment maps symptoms to potential triggers before the first session begins.
Bi-monthly dietitian + health coach sessions, unlimited messaging, and a personalized whole-body care plan. $175/month or through employer benefits at no patient cost.
CLIA-certified, CAP-accredited lab testing for vitamins, hormones, and autoimmune biomarkers - delivered and returned by mail, interpreted in clinical context.
Proprietary tool mapping symptoms to root causes before session one, so the care plan starts targeted - not generic.
Specialized tracks addressing hormonal triggers - postpartum flares and the link between hormonal imbalance and autoimmune activity, both often missed by standard care.
Self-insured employer and payer integration with group reporting and cost analytics. Covers Fortune 100/500 companies and health plan networks.
In-app peer community, food journaling, symptom tracking, and educational masterclasses. Learning to live with autoimmune disease shouldn't require a medical degree.
Ellen Rudolph, Claire Rudolph, and Wallace Torres co-found WellTheory in San Francisco after their own diagnoses reveal the care gap.
Accel leads the seed round alongside Box Group, Lux Capital, Rock Health, and Scribble Ventures. WellTheory opens to members in November 2022.
Maven Clinic becomes WellTheory's first enterprise partner. Ellen Rudolph appears on Inc. Magazine's Female Founders 200 list.
Specialized program launched targeting the intersection of hormonal imbalances and autoimmune disease - a gap that standard gynecology and rheumatology rarely bridge.
Samsung Next, Opal Ventures, and Up2 Fund join existing investors. Membership growing rapidly across B2C and enterprise channels.
Sentara Health Plans partnership announced, covering ~1 million members in Virginia and Florida with WellTheory's full 12-month program.
General Catalyst leads, joined by 7wire Ventures, Leaps by Bayer, and Ingeborg Investments. All institutional lead partners are women - a notable first in a category where 80% of patients are women.
Food-as-medicine integration provides grocery stipends to ~300,000 eligible network lives, reaching 98% of U.S. households - including 95% in food deserts.
Dedicated postpartum care track launched for new mothers navigating hormonal triggers that can cause or worsen autoimmune flares after childbirth.
WellTheory measures everything. Outcomes are tracked using clinically-validated assessments - PROMIS for general health, PHQ-9 for depression, GAD-7 for anxiety. The results are peer-review-grade, not press-release grade. An independent actuarial analysis, not an in-house study, produced the healthcare utilization numbers.
Then there's the SISC pilot - Self-Insured Schools of California, which covers 475 school districts across 44 counties. Every single participant in the pilot reported significant improvement in at least one major autoimmune area. Forty-one percent reported fewer autoimmune-related impacts on work productivity. For a population of teachers and school staff, that's not a wellness benefit. That's a retention strategy.
"Employers reported average savings of nearly $10,000 per autoimmune patient on biologics. The program effectively pays for itself within months."
- WellTheory Clinical Outcomes Report, 2025Three rounds of funding in four years, each one reflecting a different chapter in WellTheory's maturation from idea to infrastructure.
Accel, Box Group, Lux Capital, Rock Health, Scribble Ventures
Samsung Next, Opal Ventures, Up2 Fund, Accel, OVO Fund
General Catalyst, 7wire Ventures, Leaps by Bayer, Ingeborg Investments, Accel
The Series A carries an additional footnote worth registering: all institutional lead partners in the round are women. Candace Richardson and Holly Maloney at General Catalyst, Alyssa Jaffee and Tiffany Yu at 7wire Ventures. Less than 2% of VC funding goes to female-led startups in a typical year. WellTheory's Series A was led entirely by women investing in a category where 80% of patients are women. That's not a coincidence. That's pattern recognition.
WellTheory's enterprise and payer partnerships are the growth engine. Rather than waiting for individual patients to find them, the company is getting embedded in the benefit structures that already reach millions of people.
First payer partnership (June 2025). ~1 million covered lives in Virginia and Florida get full access to WellTheory's 12-month program.
Food-as-medicine integration (Nov 2025). Grocery stipends for clinically recommended foods reach 98% of U.S. households, including 95% in food deserts.
Covers 475 school districts across 44 counties. 100% of pilot participants improved in at least one major autoimmune area.
First enterprise partner (2023). Expands women's health access through combined offering.
Enterprise employer partnership providing WellTheory as a covered benefit for employees.
Enterprise employer partnership extending WellTheory access across the workforce platform.
Autoimmune disease rates have been rising for decades. The reasons are complex - gut microbiome disruption, environmental factors, stress - but the trend line is not ambiguous. More people will be diagnosed. More will spend years undiagnosed. More will find the existing system inadequate.
WellTheory's bet is that the care model that works - personalized, lifestyle-focused, practitioner-supported, measurement-driven - can be delivered at scale through a combination of technology, human coaching, and smart distribution. The Instacart partnership is a clue: the company is thinking about food access, not just food advice. Getting clinically recommended groceries to 98% of U.S. households, including food deserts, is a structural intervention, not a wellness perk.
The Postpartum Autoimmune Program launched in January 2026 - because childbirth can trigger autoimmune flares in women who were previously managing well. WellTheory is building the programs that no one else is building because no one else is paying attention to the right data.
Back in that waiting room, the woman with Hashimoto's will still wait eleven minutes. But the next time her employer benefits renew, or her health plan updates its provider network, or she searches for something that actually helps - WellTheory is where that search ends. The company has built the infrastructure for that meeting to happen at scale.
The care that should have always existed is finally arriving. It's just taking the form of an app, a dietitian who has the same disease, and a box of lab kits that arrive by mail. That's not what medicine predicted. It's what the 50 million patients demanded.